Findings

What do systematic reviews say?

3,429 questions · 3,558 findings · 436 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 660 · 18.5%GRADE not reported 375 · 10.5%Very low 727 · 20.4%Low 887 · 24.9%Moderate 709 · 19.9%High 200 · 5.6%

Summary of findings: nitric oxide vs placebo

QoL · children (12 or over) and young adults with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: nitric oxide vs placebo

Sputum microbiology · children (12 or over) and young adults with cystic fibrosis

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 30 participants
Very low

Summary of findings: nitric oxide vs placebo

Inflammatory markers · children (12 or over) and young adults with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: β‐carotene vs placebo

Adverse events · adults and children with cystic fibrosis

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 24 participants
Low

Zinc vs placebo

FEV1 % predicted · children with cystic fibrosis

It is very uncertain whether summary of findings: Zinc supplementation changes respiratory function mean FEV1 % predicted compared with placebo (very low certainty).

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 62 participants
Very low

Zinc vs placebo

Adverse events number of participants hospitalised during the trial · children with cystic fibrosis

Summary of findings: Zinc supplementation showed no clear difference in adverse events number of participants hospitalised during the trial compared with placebo (moderate certainty).

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
RR 1.23 [0.51, 2.97]
1 study · 37 participants
Moderate

Zinc vs placebo

Need for antibiotics days of antibiotic use · children with cystic fibrosis

It is very uncertain whether summary of findings: Zinc supplementation changes need for antibiotics number of days on IV or oral antibiotics compared with placebo (very low certainty).

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
MD 0.52
2 studies · 62 participants
Very low

Zinc vs placebo

QoL · children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc vs placebo

Sputum microbiology · children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc vs placebo

Inflammatory markers · children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: β‐carotene vs placebo

QoL · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: β‐carotene vs placebo

Sputum microbiology · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings: β‐carotene vs placebo

Inflammatory markers · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Time in MVPA · people with COPD, clinical stability

1 finding from 1 review

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 411 participants
Low

Intervention not reported

Time in moderate‐intensity physical activity · people with COPD, clinical stability

1 finding from 1 review

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 35 participants
Low

Intervention not reported

Change in time in MVPA · people with COPD, clinical stability

1 finding from 1 review

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 131 participants
Moderate

Intervention not reported

Time in MVPA · people with COPD, clinical stability

1 finding from 1 review

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 426 participants
Moderate

Intervention not reported

Change in time in MVPA · people with COPD, clinical stability

1 finding from 1 review

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Intervention not reported

Time in MVPA · people with COPD, clinical stability

1 finding from 1 review

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Low

Intervention not reported

Time in moderate‐intensity physical activity · people with COPD, clinical stability

1 finding from 1 review

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD) 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 97 participants
Moderate